Search Results 1581-1590 of 20501 for hepatitis

1. A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   Positive test for human immunodeficiency virus (HIV) and/or active hepatitis B or hepatitis C or tuberculosis; Severe infections within 4 weeks prior to ...

2. Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   Patients with a history of human immunodeficiency virus (HIV) or active infection with hepatitis B virus (HBV) or hepatitis C virus (HCV). Patients with any ...

3. A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, or T-cell Lymphoma - Mayo Clinic

   - Active tuberculosis or hepatitis, or history of hepatitis B or C, or chronic hepatitis - Any of the following prior therapies: - Chemotherapy (IMIDs ...

4. A Study to Evaluate the Safety, Tolerability and Effectiveness of V117957 in Subjects with Insomnia Associated with Alcohol Cessation - Mayo Clinic

   Known history of testing positive for human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg) or hepatitis C antibody (anti-HCV). History of ...

5. A Study to Evaluate the Use of Adipose-derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis - Mayo Clinic

   Known history of HIV, or has active Hepatitis B or active Hepatitis C. Disease or medication-related disorder of coagulation (i.e., elevated PTT > 13.8 ...

6. Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects - Mayo Clinic

   disease, viral hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune hepatitis, Wilson's disease, hemochromatosis, alpha-1 ...

7. Surgery - Doctors - Mayo Clinic

   ... hepatitis, Autoimmune hepatitis, Hepatocellular carcinoma, Wilson's disease, Hepatopulmonary syndrome, Primary biliary cholangitis, Portopulmonary ...

8. Digestive Diseases Physicians - Medical Professionals - Mayo Clinic

   Nonalcoholic fatty liver disease, Cirrhosis, Hepatitis C, Hepatitis B, Alcoholic hepatitis, Viral hepatitis, Hepatic encephalopathy ...

9. Assessing Benefits And Harms Of Cannabis/Cannabinoid Use Among Cancer Patients Treated In Community Oncology Clinics

   * Participants with a history of HIV, hepatitis B or hepatitis C. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last ...

10. Symptoms and causes - Mayo Clinic

    These include diabetes, lupus, obesity and other kidney diseases. Certain infections. Infections that increase the risk of FSGS include HIV and hepatitis C.